RECOVER: Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Recruiting
18-99 years
All
Phase
N/A
30 participants needed
1 Location
Brief description of study
The research study is being conducted to determine if active VNS (Vagus Nerve Stimulation) Therapy helps depression subjects compared to a no-stimulation control group. Patients with an established diagnosis with Treatment-Resistant Depression (TRD) and have been referred for treatment with the VNS Therapy® System will potentially qualify to participate in the study.
Final eligibility is based upon medical record review by the research investigator and the research team.
All subjects in this study will receive a VNS Therapy implant and all subjects will receive active VNS Therapy. VNS Therapy was approved by the United States Food and Drug Administration (FDA) in 2005, on the basis of previous research, as a safe and effective add-on treatment for people with Treatment-Resistant Depression. VNS Therapy has been used to treat over 4,000 patients with Treatment-Resistant Depression in the US.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: depression,treatment resistant depression,vagus nerve stimulation
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 844300
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
